| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.08B | $2.98B | $3.10B |
| YoY Revenue Growth % | +3.2% | -3.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $561.6M | $537.0M | $543.4M |
| Operating Margin % | 18.3% | 18.0% | 17.6% |
| Net Income (GAAP) | $406.1M | $422.2M | $376.9M |
| EBITDA (Normalized) | $617.5M | $603.2M | $654.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $511.0M | $427.5M | $455.0M |
| Capital Expenditures (CapEx) | $69.9M | $82.7M | $139.3M |
| Free Cash Flow (FCF) | $441.1M | $344.8M | $315.7M |
| FCF Margin % | 14.3% | 11.6% | 10.2% |
| Return on Invested Capital (ROIC %) | 18.9% | 15.2% | 19.1% |
| Cash & Short-Term Equivalents | $492.2M | $356.4M | — |
| Total Debt (Short + Long Term) | $1.59B | $2.09B | $869.1M |
| Total Stockholders' Equity | $1.24B | $1.05B | $1.78B |